✦ LIBER ✦

End-Stage Cardiomyopathy Because of Hereditary Hemochromatosis Successfully Treated With Erythrocytapheresis in Combination With Left Ventricular Assist Device Support

✍ Scribed by Rombout-Sestrienkova, E.; De Jonge, N.; Martinakova, K.; Klopping, C.; van Galen, K. P. M.; Vink, A.; Wajon, E. M. C. J.; Smit, W. M.; van Bree, C.; Koek, G. H.

Book ID: 125505469
Publisher: Ovid Technologies Wolters Kluwer -American Heart Association
Year: 2014
Tongue: English
Weight: 554 KB
Volume: 7
Category: Article
ISSN: 1941-3289
DOI: 10.1161/CIRCHEARTFAILURE.114.001198

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effect of left ventricular assist device

Effect of left ventricular assist device combination therapy on myocardial blood flow in patients with end-stage dilated cardiomyopathy

✍ Patrick Tansley; Magdi Yacoub; Ornella Rimoldi; Emma Birks; James Hardy; Mandy H 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 113 KB

Management of patients with end-stage he

Management of patients with end-stage heart disease treated with an implantable left ventricular assist device in a nontransplanting center

✍ Bengt Peterzén; Hans Granfeldt; Urban Lönn; Bo Carnstam; Eva Nylander; Ulf Dahls 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 60 KB

Evaluation of myocardial function in pat

Evaluation of myocardial function in patients with end-stage heart failure during support with the Jarvik 2000 left ventricular assist device

✍ Markus Ferrari; Kamuran A. Kadipasaoglu; Mihai Croitoru; Jeff Conger; Tim Myers; 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 78 KB

Cardiomyocyte death in patients with end

Cardiomyocyte death in patients with end-stage heart failure before and after support with a left ventricular assist device: low incidence of apoptosis despite ubiquitous mediators

✍ Nicolaas de Jonge; Dick F van Wichen; Joyce van Kuik; Hans Kirkels; Jaap R Lahpo 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 277 KB